Skip to content

Opioid-free total intravenous anesthesia for thyroid and parathyroid surgery: a randomized, double-blind, controlled trial

Opioid-free total intravenous anesthesia for thyroid and parathyroid surgery: a randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059656
Enrollment
Unknown
Registered
2022-05-05
Start date
2022-05-10
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia for thyroid and parathyroid surgery

Interventions

Opioid-free anesthesia (OFA):Esketamine, lidocaine, dexmedetomidine, and propofol
Opioid-based anesthesia (OA):Sufentanil and propofol

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 18 years; 2. ASA classification I~III; 3. Thyroid and parathyroid surgery under selective general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Goiter causes tracheal compression or dyspnea; 2. Hyperthyroidism or hypothyroidism; 3. Obstructive sleep apnea syndrome; 4. Left ventricular ejection fraction<40%, second degree or more atrioventricular block, sick sinus syndrome, or severe bradycardia (heart rate [HR]<50 beats/min); 5. Severe hepatic and renal insufficiency (Child Pugh C grade or renal replacement therapy required); 6. Convulsions or seizures; 7. Chronic pain or use sedatives and analgesics before operation; 8. Allergy to any drug used in this study; 9. Pregnancy or lactation; 10. Unable to communicate before operation.

Design outcomes

Secondary

MeasureTime frame
the severity of PONV;antiemetic rescue therapy;pain scores at rest and while coughing;need for rescue analgesia;adverse effects related to anesthetics or analgesics (hypotension, bradycardia, desaturation, dizziness, headache, hallucination, and nightmare);time to extubation;length of PACU stay;length of postoperative hospital stay;patient satisfaction;a composite variable of 30-day major adverse events (myocardial infarction, cardiac arrest, cerebrovascular accident, coma, acute renal failure, pulmonary embolism, sepsis, septic shock, deep neck space infection, reintubation, reoperation, blood transfusion, failure to wean off ventilator, and death);

Primary

MeasureTime frame
incidence of postoperative nausea and vomiting (PONV);

Countries

China

Contacts

Public ContactPeng Ke

The First Affiliated Hospital of Soochow University?

pengke0422@163.com+86 15962155989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026